← Leaderboards
Paul H Patterson
California Institute Of Technology
$9,642,207
Attributed
$9,921,275
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–13$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$9,921,275 · 11
By mechanism
R01$9,543,538 · 7
P51$377,737 · 4
Top collaborators
- Sarkis K Mazmanian1 shared
Most similar at California Institute Of Technology
Same institution · by research overlap
- Joanna L Jankowsky$20,075,224
- Michael P Lamb$3,335,662
Others in their field
Top investigators on “Neuropathology”
- David A Bennett · Rush University Medical Center$111,639,166
- Walter A Kukull · University Of Washington$75,528,085
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$69,902,351
- Michael W Weiner · Northern California Institute Res &Educ$59,722,057
- John Morris · Washington University$56,890,430
- Reisa A. Sperling · Banner Health$56,277,198
Research focus
NeuropathologyBrainResearch StudyMouse ModelNeuronsAnimal ModelBehavioralSymptomsBaseMotorAnimalsAdultIn VivoPathologyRespiratory Tract InfectionsInvestigationSocial InteractionResearch PersonnelMediatingOffspringExhibitsCellsNovel TherapeuticsInjection Of Therapeutic Agent
Grant awards (31)
Investigating the Gut Microbiome for Novel Therapies and Diagnostics for Autism$558,136
R01 · FY2013 · MH · contact PI
Validation of IKKbeta as a therapeutic target for HD$346,194
R01 · FY2013 · NS · contact PI
Validation of IKKbeta as a therapeutic target for HD$358,750
R01 · FY2012 · NS · contact PI
Evaluation of Mouse Hallucinations by fMRI$311,915
R01 · FY2012 · MH · contact PI
Intrabodies For Huntington's Disease Therapy$384,506
R01 · FY2011 · NS · contact PI
Validation of IKKbeta as a therapeutic target for HD$358,750
R01 · FY2011 · NS · contact PI
Evaluation of Mouse Hallucinations by fMRI$312,086
R01 · FY2011 · MH · contact PI
A NON-HUMAN PRIMATE AUTISM MODEL BASED ON MATERNAL IMMUNE ACTIVATION$75,629
P51 · FY2011 · RR · contact PI
Mobilizing Adult Neural Stem Cells and Disease Models$435,353
R01 · FY2010 · NS · contact PI
Intrabodies For Huntington's Disease Therapy$384,019
R01 · FY2010 · NS · contact PI
Evaluation of Mouse Hallucinations by fMRI$315,406
R01 · FY2010 · MH · contact PI
A NON-HUMAN PRIMATE AUTISM MODEL BASED ON MATERNAL IMMUNE ACTIVATION$114,105
P51 · FY2010 · RR · contact PI
Mobilizing Adult Neural Stem Cells and Disease Models$441,372
R01 · FY2009 · NS · contact PI
Intrabodies For Huntington's Disease Therapy$375,296
R01 · FY2009 · NS · contact PI
Evaluation of Mouse Hallucinations by fMRI$315,406
R01 · FY2009 · MH · contact PI
A NON-HUMAN PRIMATE AUTISM MODEL BASED ON MATERNAL IMMUNE ACTIVATION$106,670
P51 · FY2009 · RR · contact PI
Intrabodies For Huntington's Disease Therapy$365,989
R01 · FY2008 · NS · contact PI
Maternal Viral Infection and Fetal Brain Development$307,210
R01 · FY2008 · MH · contact PI
A NON-HUMAN PRIMATE AUTISM MODEL BASED ON MATERNAL IMMUNE ACTIVATION$81,333
P51 · FY2008 · RR · contact PI
Intrabodies For Huntington's Disease Therapy$354,870
R01 · FY2007 · NS · contact PI
LIF and Cell Renewal in Hippocampus and Olfactory Bulb$319,691
R01 · FY2007 · NS · contact PI
Maternal Viral Infection and Fetal Brain Development$307,210
R01 · FY2007 · MH · contact PI
LIF and Cell Renewal in Hippocampus and Olfactory Bulb$329,239
R01 · FY2006 · NS · contact PI
Maternal Viral Infection and Fetal Brain Development$316,386
R01 · FY2006 · MH · contact PI
The Role of NFkB in Huntington's Disease$342,741
R01 · FY2005 · NS
LIF and Cell Renewal in Hippocampus and Olfactory Bulb$337,163
R01 · FY2005 · NS
Maternal Viral Infection and Fetal Brain Development$324,000
R01 · FY2005 · MH
Maternal Viral Infection and Fetal Brain Development$364,500
R01 · FY2004 · MH
The Role of NFkB in Huntington's Disease$342,741
R01 · FY2004 · NS
LIF and Cell Renewal in Hippocampus and Olfactory Bulb$330,343
R01 · FY2004 · NS
The Role of NFkB in Huntington's Disease$304,266
R01 · FY2003 · NS